OXYGEN 99.0 % — DIN 02248726
OXYGEN : 99.0 % · INDEPENDENT RESPIRATORY SERVICES (2016) INC. · GAS · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is OXYGEN?
OXYGEN 99.0 % contains OXYGEN : 99.0 %. It is listed in the Health Canada Drug Product Database under DIN 02248726, held by INDEPENDENT RESPIRATORY SERVICES (2016) INC., supplied as GAS for INHALATION administration. Health Canada currently lists it as cancelled post market, status dated 31-Mar-2019. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Oxygen cost around the world?
Oxygen is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Hungary publishes a producer price (ex-factory); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Hungary | producer price (ex-factory) | 6 | 6 | HUF███.██ |
| Luxembourg | reimbursement | 4 | 4 | EUR███.██ |
10 pack listings across 10 brand entries and 2 price bases, refreshed 05 Sep 2026. Ranges span every Oxygen pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Oxygen in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
44 holders have a Canadian DIN containing Oxygen, across 46 DINs, of which 12 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AIR PRODUCTS CANADA LTD/LTÉE. | 2 | 1 | AIR COMPRESSED, OXYGEN 99.0% | Sourceable in Canada |
| AIR LIQUIDE CANADA INC. | 1 | 1 | OXYGEN 100% | Sourceable in Canada |
| GASPRO, DIVISION OF PRORESP INC. | 1 | 1 | OXYGEN USP | Sourceable in Canada |
| HURONIA/MED-E-OX LTD. | 1 | 1 | OXYGEN USP | Sourceable in Canada |
| LAKERIDGE HEALTH CORPORATION COMMUNITY RESPIRATORY SERVICES | 1 | 1 | OXYGEN USP - GAS 100% | Sourceable in Canada |
| LINDE CANADA INC. | 1 | 1 | OXYGEN USP | Sourceable in Canada |
| MAGGAS MEDICAL INC. | 1 | 1 | OXYGEN U.S.P. | Sourceable in Canada |
| MESSER CANADA INC. | 1 | 1 | OXYGEN USP | Sourceable in Canada |
| ONTARIO HOME OXYGEN AND RESPIRATORY SERVICE INC. | 1 | 1 | OXYGEN USP | Sourceable in Canada |
| ONTARIO MEDICAL OXYGEN SERVICES INC. | 1 | 1 | OXYGEN | Sourceable in Canada |
| OXYMED, DIV. DE 118303 CANADA INC. | 1 | 1 | OXYGEN USP | Sourceable in Canada |
| PREVIMED INC. | 1 | 1 | OXYGENE - GAS INH | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 99.0 % |
|---|---|
| Dosage form | GAS |
| Route | INHALATION |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Oxygen |
|---|---|
| ATC code | V03AN01 |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02248726 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2248726 |
| Brand name | OXYGEN |
| Generic / active ingredient | OXYGEN : 99.0 % |
| Market authorization holder | INDEPENDENT RESPIRATORY SERVICES (2016) INC. |
| Health Canada schedule | Ethical |
| ATC code | V03AN01 |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V03AN |
| Current status | CANCELLED POST MARKET |
| Status date | 31-Mar-2019 |
| Original market date | 2004-01-30 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
12 of 46 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| OXYGEN | 99.5 % | GAS | ONTARIO MEDICAL OXYGEN SERVICES INC. | MARKETED | 02474298 |
| OXYGEN 100% | 100 % | GAS | AIR LIQUIDE CANADA INC. | MARKETED | 00572810 |
| OXYGEN 99.0% | 99.0 % | GAS | AIR PRODUCTS CANADA LTD/LTÉE. | MARKETED | 00591629 |
| OXYGEN U.S.P. | 99.99 % | GAS | MAGGAS MEDICAL INC. | MARKETED | 02230956 |
| OXYGEN USP | 99 % | GAS | OXYMED, DIV. DE 118303 CANADA INC. | MARKETED | 02247852 |
| OXYGEN USP | 99 % | GAS | MESSER CANADA INC. | MARKETED | 02154838 |
| OXYGEN USP | 99.5 % | GAS | GASPRO, DIVISION OF PRORESP INC. | MARKETED | 02052881 |
| OXYGEN USP | 99 % | GAS | LINDE CANADA INC. | MARKETED | 02014408 |
| OXYGEN USP | 99 % | GAS | HURONIA/MED-E-OX LTD. | MARKETED | 02240621 |
| OXYGEN USP | 99 % | GAS | ONTARIO HOME OXYGEN AND RESPIRATORY SERVICE INC. | MARKETED | 02242542 |
2 · Same class — other molecules in ATC V03AN
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Oxygen | AIR COMPRESSED · EMERGENCY OXYGEN SUPPLY 99.5% · LIQUID OXYGEN · MADACYLINDER 99.5% · +21 more | 46 | 12 | Yes |
| Medical Gases | CARBON DIOXIDE 1% W OXYGEN · CARBON DIOXIDE 12.1% W OXYGEN · CARBON DIOXIDE 23.1% W OXYGEN · CARBON DIOXIDE 7.1% W OXYGEN · +19 more | 23 | 8 | Yes |
| Combination | CARBOGEN · CARBON DIOXIDE USP, OXYGEN USP MEDICAL G.M. · CO-HE-O2-N2 MIXTURE · CO-NE-O2-N2 MIXTURE · +4 more | 8 | 8 | Yes |
| Nitrogen | GASEOUS NITROGEN 99.0% · LIQUID NITROGEN · LIQUID NITROGEN NF · NITROGEN · +5 more | 14 | 7 | Yes |
| Medical Air | AIR, COMPRESSED GAS 99% · CARBON DIOXIDE 1% W AIR · CARBON DIOXIDE 15.1% W AIR · CARBON DIOXIDE 30.1% W AIR · +6 more | 11 | 3 | Yes |
| Carbon Dioxide | CARBON DIOXIDE 100% · CARBON DIOXIDE U.S.P · CARBON DIOXIDE USP | 5 | 3 | Yes |
| Helium | HELIUM 100% · HELIUM COMPRESSED USP · HELIUM USP | 5 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC V03A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| V03AC | Deferasirox · Deferiprone · Deferoxamine | 57 | 44 |
| V03AB | Amyl Nitrite · Andexanet Alfa · Antidotes · Digitalis Antitoxin · Dimercaprol · +16 more | 87 | 31 |
| V03AE | Calcium Acetate · Drugs For Treatment Of Hyperkalemia And Hyperphosphatemia · Lanthanum Carbonate · Patiromer Calcium · Polystyrene Sulphonate · +3 more | 40 | 19 |
| V03AF | Amifostine · Calcium Folinate · Dexrazoxane · Mesna · Palifermin · +1 more | 34 | 16 |
| V03AH | Diazoxide | 2 | 1 |
| V03AX | Cobicistat · Difelikefalin · Other Therapeutic Products | 8 | 1 |
| V03AZ | Ethanol | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.